ProCE Banner Activity

Comprehensive Slides on State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care

Slideset Download

This slideset provides an overview of the latest data on ART safety and tolerability, emphasizing unique populations such as pregnant women, aging patients, populations with cardiometabolic toxicities, and transgender persons.

Released: November 28, 2022

Begin Activity

Share

Faculty

Jean Rene Anderson

Jean Rene Anderson, MD

Professor
Department of Gynecology and Obstetrics
Johns Hopkins University
Director, Johns Hopkins HIV Women’s Health Program
Johns Hopkins Medical Institutions
Baltimore, Maryland

Jill Blumenthal

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Marta Boffito

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director
HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital NHS Foundation Trust
Imperial College London
London, UK 

Jennifer Cocohoba

Jennifer Cocohoba, PharmD

Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Womens HIV Program
University of California San Francisco Medical Center
San Francisco, California

Joseph J. Eron Jr.

Joseph J. Eron Jr., MD

Herman and Louise Smith Distinguished Professor of Medicine
Chief, Division of Infectious Diseases
UNC-Chapel Hill School of Medicine
Chapel Hill, North Carolina

Julian Falutz

Julian Falutz, MD, FRCPC

Associate Professor of Medicine
Department of Medicine
McGill University School of Medicine
Director
Comprehensive HIV and Aging Initiative
Chronic Viral Illness Service
McGill
Montreal, Quebec, Canada

Eric K. Farmer

Eric K. Farmer, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist
LifeCare Clinic
Indiana University Health
Indianapolis, Indiana

Priscilla Y. Hsue

Priscilla Y. Hsue, MD

Professor of Medicine
University of California at
San Francisco
San Francisco General Hospital
San Francisco, California

David Koren

David Koren, PharmD, MPH

Clinical Pharmacist Specialist
Temple University Health System
Philadelphia, Pennsylvania

Jens D. Lundgren

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Aadia Rana

Aadia Rana, MD

Associate Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham
1917 Clinic
Birmingham, Alabama

William R. Short

William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Darcy Wooten

Darcy Wooten, MD, MS

Clinical Professor of Medicine
ID Fellowship Program Director
Division of Infectious Diseases and Global Public Health
University of California
San Diego, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP and ViiV Healthcare.

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Faculty Disclosure

Primary Author

Jean Rene Anderson, MD

Professor
Department of Gynecology and Obstetrics
Johns Hopkins University
Director, Johns Hopkins HIV Women’s Health Program
Johns Hopkins Medical Institutions
Baltimore, Maryland

Jean Rene Anderson, MD: researcher: Gilead Sciences; individual publicly traded stocks and stock options: AbbVie, Merck.

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jill Blumenthal, MD, MAS: researcher: Gilead Sciences.

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director
HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital NHS Foundation Trust
Imperial College London
London, UK 

Marta Boffito, MD, PHD, FRCP: consultant/advisor/speaker: AstraZeneca, Atea, Gilead, Merck Sharp and Doheme, Pfizer, Roche, ViiV.

Jennifer Cocohoba, PharmD

Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Womens HIV Program
University of California San Francisco Medical Center
San Francisco, California

Jennifer Cocohoba, PharmD: researcher: Genentech, Janssen, ViiV Healthcare, Walgreens.

Joseph J. Eron Jr., MD

Herman and Louise Smith Distinguished Professor of Medicine
Chief, Division of Infectious Diseases
UNC-Chapel Hill School of Medicine
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, Merck, ViiV; researcher: Gilead Sciences, ViiV.  

Julian Falutz, MD, FRCPC

Associate Professor of Medicine
Department of Medicine
McGill University School of Medicine
Director
Comprehensive HIV and Aging Initiative
Chronic Viral Illness Service
McGill
Montreal, Quebec, Canada

Julian Falutz, MD, FRCPC: consultant/advisor/speaker: Gilead Sciences, Merck, ViiV Healthcare.

Eric K. Farmer, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist
LifeCare Clinic
Indiana University Health
Indianapolis, Indiana

Eric K. Farmer, PharmD, BCPS, AAHIVP: consultant/advisor/speaker: Theratechnologies, ViiV Healthcare.

Priscilla Y. Hsue, MD

Professor of Medicine
University of California at
San Francisco
San Francisco General Hospital
San Francisco, California

Priscilla Y. Hsue, MD: consultant/advisor/speaker: Gilead Sciences, Merck; researcher: Novartis.

David Koren, PharmD, MPH

Clinical Pharmacist Specialist
Temple University Health System
Philadelphia, Pennsylvania

David Koren, PharmD, MPH: consultant/advisor/speaker: Gilead sciences, ViiV Healthcare.

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant financial relationships to disclose.

Aadia Rana, MD

Associate Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham
1917 Clinic
Birmingham, Alabama

Aadia Rana, MD: researcher: Merck.

William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

William R. Short, MD, MPH, AAHIVS: fees for non-CME/CE services: Janssen; consultant: ViiV Healthcare.

Darcy Wooten, MD, MS

Clinical Professor of Medicine
ID Fellowship Program Director
Division of Infectious Diseases and Global Public Health
University of California
San Diego, California

Darcy Wooten, MD, has no relevant financial relationships to disclose.